Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DARWIN: Description of Apremilast Real World Italian Psoriasis Network - a Multicenter, Observational, Cross-sectional Study to Describe Patient Characteristics and Treatment Pattern

NCT04031027 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT04031027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04031027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DARWIN: Description of Apremilast Real World Italian Psoriasis Network - a Multicenter, Observational, Cross-sectional Study to Describe Patient Characteristics and Treatment Pattern
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
July 22, 2019
Completion date
January 27, 2021
Enrollment
184 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis